The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Gender Differences in the Prescribing of Antipsychotic Drugs
Abstract
OBJECTIVE: The aim of this article is to offer recommendations and rationale for gender-specific antipsychotic treatment. METHOD: The author summarizes reviews of recent literature in psychiatric clinical trials, pharmacology, drug safety, toxicology, obstetrics and gynecology, and pediatrics. RESULTS: The pharmacokinetics and pharmacodynamics of antipsychotic drugs differ in women and men and are influenced by gender-specific factors such as body build, diet, smoking, concurrent medication, exercise, substance use, and hormonal transitions. In general, and for some drugs in particular, women require lower doses in order to stay well. Because preliminary drug testing is not done in pregnant women, the issue of effective dosing during pregnancy is unstudied, and safety for fetuses and nursing infants may not become evident until a drug is widely used. Specific adverse effects on issues crucial to women (e.g., parenting) have not been well studied, but some side effects, such as weight gain, passivity, hypotension, and hyperprolactinemia, are reported to be particularly problematic for women. Some serious side effects are more often seen among women than among men. CONCLUSIONS: Optimal maintenance regimens of antipsychotics for women and men are not the same.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Howard, R., Rabins, P. V., Seeman, M. V., Jeste, D. V., & Late-Onset, T. I. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.172 · Cited by 678
Self-citationDopamine Antagonists and the Development of Breast Cancer
Wang, P. S., Walker, A. M., Tsuang, M. T., Orav, E. J., Glynn, R. J., Levin, R., & Avorn, J. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1147 · Cited by 196
Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents
Naidoo, U., Goff, D. C., & Klibanski, A. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00129-4 · Cited by 113
Becker, D., Liver, O., Mester, R., Rapoport, M., Weizman, A., & Weiss, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0704 · Cited by 107 · cited 1×
“Women taking drugs that raise prolactin levels show decreased bone mineral density relative to women treated with drugs less prone to increase prolactin (105, 106).”
Abraham, G., Paing, W. W., Kaminski, J., Joseph, A., Kohegyi, E., & Josiassen, R. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1618 · Cited by 82
Kamimori, G. H., Joubert, A., Otterstetter, R., Santaromana, M., & Eddington, N. D. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050654 · Cited by 49
Cited by
A Review of Postpartum Psychosis
Sit, D., Rothschild, A. J., & Wisner, K. L. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.352 · Cited by 454
Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
Foley, D. L., & Morley, K. I. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2 · Cited by 287
Davey, K. J., O’Mahony, S. M., Schellekens, H., O’Sullivan, O., Bienenstock, J., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2555-2 · Cited by 275
Poison center consultation reduces hospital length of stay
Farkas, A., Kostic, M., Huang, C.-C., & Gummin, D. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2039686 · Cited by 14
Metadata
- Authors
- Seeman, M. V.
- Venue
- American Journal of Psychiatry
- Published
- 2004-08-01
- Volume
- 161
- Issue
- 8
- Pages
- 1324-1333
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2151784172
- Cited by
- 219
- References
- 7
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.